[fam-] trastuzumab deruxtecan (DS-8201) - Daiichi Sankyo
Keytruda (pembrolizumab) - Merck (MSD)
DS-8201 + Keytruda: Initiation of P1b trial for breast cancer in Q3 FY 2019 (Daiichi Sankyo) - Apr 26, 2019 - FY 2018 Results 
New P1 trial
https://www.daiichisankyo.com/media_investors/investor_relations/ir_calendar/files/005439/FY2018%20Q4_Presentation%20Material.pdf
 
Apr 26, 2019
 
 
74504f4f-178f-4d12-84fb-a4eee1019e15.jpg